Author:
Li Hong,Guo Feng,Luo Yu-chun,Zhu Jian-ping,Wang Jian-liang
Publisher
Springer Science and Business Media LLC
Subject
General Medicine,Rheumatology
Reference30 articles.
1. Jenkinson TR, Mallorie PA, Whitelock HC, Kennedy LG, Garrett SL, Calin A (1994) Defining spinal mobility in ankylosing spondylitis (AS). The Bath AS Metrology Index. J Rheumatol 21(9):1694–1698
2. van der Linden S, van der Heijde D (1998) Ankylosing spondylitis. Clinical features. Rheum Dis Clin N Am 24(4):663–676, vii
3. Shen TC, Lin CL, Wei CC, Chen CH, Tu CY, Hsia TC, Shih CM, Hsu WH, Sung FC (2015) The risk of asthma in patients with ankylosing spondylitis: a population-based cohort study. PLoS One 10(2):e0116608. doi: 10.1371/journal.pone.0116608
4. Ji W, Li H, Gao F, Chen Y, Zhong L, Wang D (2014) Effects of glycosides on interleukin-17 and CD4CD25CD127 regulatory T-cell expression in the peripheral blood of patients with ankylosing spondylitis. Biomed Rep 2(4):517–520. doi: 10.3892/br.2014.262
5. Su MX, Zhou WD, Lan J, Di B, Hang TJ (2014) Rapid and sensitive analysis of multiple bioactive constituents in tripterygium glycosides tablets using liquid chromatography coupled with time-of-flight mass spectrometry. J Sep Sci. doi: 10.1002/jssc.201400946